172 related articles for article (PubMed ID: 31140843)
1. Luteinizing hormone receptor expression by nonneoplastic and neoplastic canine lymphocytes.
Ettinger AM; Gust SK; Kutzler MA
Am J Vet Res; 2019 Jun; 80(6):572-577. PubMed ID: 31140843
[TBL] [Abstract][Full Text] [Related]
2. Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.
Zwingenberger AL; Kent MS; Shi C; Taylor SL; Chen X; Lam KS
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):298-304. PubMed ID: 22177114
[TBL] [Abstract][Full Text] [Related]
3. Checkpoint molecule expression by B and T cell lymphomas in dogs.
Hartley G; Elmslie R; Dow S; Guth A
Vet Comp Oncol; 2018 Sep; 16(3):352-360. PubMed ID: 29380929
[TBL] [Abstract][Full Text] [Related]
4. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
5. CD45+ and CD45- lymphocyte populations identified by flow cytometry from dogs with lymphoma exhibit similar morphology and the same clonal (B cell or T cell) lineage.
Fogle JE; Tarigo JL; Thalheim L; Williams LE; English LB; Suter SE
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):242-8. PubMed ID: 26553299
[TBL] [Abstract][Full Text] [Related]
6. Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.
Meichner K; Fogle JE; English L; Suter SE
J Vet Intern Med; 2016 May; 30(3):819-26. PubMed ID: 27013187
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of canine nodal T-cell lymphomas classified as CD8+ or CD4-CD8- by flow cytometry.
Harris LJ; Rout ED; Labadie JD; Avery PR; Fernandez M; Yoshimoto J; Avery AC
Vet Comp Oncol; 2020 Sep; 18(3):416-427. PubMed ID: 31951040
[TBL] [Abstract][Full Text] [Related]
8. Understanding the effects of sustained supraphysiologic concentrations of luteinizing hormone in gonadectomized dogs: What we know and what we still need to learn.
Kutzler MA
Theriogenology; 2023 Jan; 196():270-274. PubMed ID: 36459946
[TBL] [Abstract][Full Text] [Related]
9. Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma.
Culmsee K; Simon D; Mischke R; Nolte I
J Vet Med A Physiol Pathol Clin Med; 2001 May; 48(4):199-206. PubMed ID: 11413979
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression study of proapoptotic BH3-only protein bad in canine nonneoplastic tissues and canine lymphomas.
Dettwiler M; Croci M; Vaughan L; Guscetti F
Vet Pathol; 2013 Sep; 50(5):789-96. PubMed ID: 23417166
[TBL] [Abstract][Full Text] [Related]
11. Detection of retinoid receptors in non-neoplastic canine lymph nodes and in lymphoma.
de Mello Souza CH; Valli VE; Kitchell BE
Can Vet J; 2014 Jan; 55(1):1219-24. PubMed ID: 24381339
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing Hormone Receptor Expression in Neoplastic Mast Cells Is Increased in Spayed and Neutered Dogs.
Anne Kutzler M; Moccia V; Zwida K; Verena Löhr C
J Am Anim Hosp Assoc; 2022 Nov; 58(6):271-276. PubMed ID: 36315865
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factors and receptors in Canine Lymphoma.
Aricò A; Guadagnin E; Ferraresso S; Gelain ME; Iussich S; Rütgen BC; Mazzariol S; Marconato L; Aresu L
J Comp Pathol; 2014 Nov; 151(4):322-8. PubMed ID: 25172054
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric immunophenotype of canine lymph node aspirates.
Gibson D; Aubert I; Woods JP; Abrams-Ogg A; Kruth S; Wood RD; Bienzle D
J Vet Intern Med; 2004; 18(5):710-7. PubMed ID: 15515589
[TBL] [Abstract][Full Text] [Related]
15. Canine CD4+ T-cell lymphoma identified by flow cytometry exhibits a consistent histomorphology and gene expression profile.
Harris LJ; Hughes KL; Ehrhart EJ; Labadie JD; Yoshimoto J; Avery AC
Vet Comp Oncol; 2019 Sep; 17(3):253-264. PubMed ID: 30684308
[TBL] [Abstract][Full Text] [Related]
16. Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet).
Ito D; O'Brien TD; Modiano JF
Vet Clin Pathol; 2010 Dec; 39(4):494-8. PubMed ID: 21198735
[TBL] [Abstract][Full Text] [Related]
17. Lymphocytosis and lymphadenopathy in a dog arising from two distinct lymphoid neoplasms.
Long ME; Evans B; Avery AC; Wellman ML
Vet Clin Pathol; 2020 Jun; 49(2):307-311. PubMed ID: 32347563
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte responsiveness to mitogens and quantitation of T and B lymphocytes in canine malignant lymphoma.
Dutta SK; Novilla MN; Bumgardner MK; Ingling A
Am J Vet Res; 1978 Mar; 39(3):455-8. PubMed ID: 305738
[TBL] [Abstract][Full Text] [Related]
19. Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression.
Martini V; Cozzi M; Aricò A; Dalla Rovere G; Poggi A; Albonico F; Mortarino M; Ciusani E; Aresu L; Comazzi S
Vet Immunol Immunopathol; 2017 May; 187():14-19. PubMed ID: 28494924
[TBL] [Abstract][Full Text] [Related]
20. Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas.
Sözmen M; Tasca S; Carli E; De Lorenzi D; Furlanello T; Caldin M
J Vet Diagn Invest; 2005 Jul; 17(4):323-30. PubMed ID: 16130989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
